ClinConnect ClinConnect Logo
Search / Trial NCT04761549

3D, Dynamic and Mechanically-informed Decision Making in AIS

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Feb 15, 2021

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Adolescent Idiopathic Scoliosis (AIS) is a growth defect of the spine that primarily occurs in prepubertal children between the age of 10 to 14 years, affecting approximately 3% of these otherwise normal children. The spine, which is normally straight in a posterior view, forms one or two lateral curves with associated turns around its longitudinal axis, like a spiral staircase. AIS has been associated with problems related to posture, load-related back pain, as well as aesthetic problems, e.g. the induced asymmetry of the shoulder. Therefore, early diagnosis followed by the appropriate tre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient diagnosed with Adolescent Idiopathic Scoliosis
  • 10-35 years old
  • Patient is scheduled to be surgically treated by vertebral body tethering (VBT) or selective fusion at UZ Leuven
  • Informed consent obtained: also from parent/guardian in case of minors
  • Exclusion Criteria:
  • Patient has undergone a fusion or VBT procedure before
  • Patient has a severe underlying illness which might influence the outcome of the surgery
  • Making it reasonable for the investigator to exclude the patient

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Leuven, Vlaams Brabant, Belgium

Patients applied

0 patients applied

Trial Officials

Sebastiaan Schelfaut

Principal Investigator

Universitaire Ziekenhuizen KU Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials